Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28852631 | 0.98 | ALDH1A1 (0.49) | ALDH1A1RIPK1ALOX5TDP1EPHX2 | |
| SCHEMBL7087548 | 0.87 | ALDH1A1 (0.52) | ALDH1A1ALOX5TDP1EPHX2MAPT | |
| Charcoal, Activated SCHEMBL31384356 | 0.85 | ALDH1A1 (0.50) | ALDH1A1ALOX5TDP1EPHX2MAPT | |
| SCHEMBL29211196 | 0.85 | ALDH1A1 (0.47) | ALDH1A1RIPK1ALOX5TDP1EPHX2 | |
| SCHEMBL14680370 | 0.82 | ALDH1A1 (0.45) | ALDH1A1RIPK1ALOX5TDP1EPHX2 | |
| SCHEMBL9118516 | 0.82 | ALDH1A1 (0.47) | ALDH1A1ALOX5TDP1EPHX2MAPT | |
| SCHEMBL27512354 | 0.82 | ALDH1A1 (0.47) | ALDH1A1ALOX5TDP1EPHX2MAPT | |
| SCHEMBL12530216 | 0.81 | ALDH1A1 (0.47) | ALDH1A1RIPK1ALOX5TDP1EPHX2 | |
| SCHEMBL7901608 | 0.81 | ALDH1A1 (0.51) | ALDH1A1ALOX5TDP1EPHX2MAPT | |
| Furan SCHEMBL29001010 | 0.80 | ALDH1A1 (0.46) | ALDH1A1ALOX5TDP1EPHX2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250134141-A1 | PROCESS FOR TREATING PLANT-BASED SUBSTRATES FOR FOOD PRODUCTS | Voyage Foods, Inc. | 2025-05-01 | — | — | US | disclosed |
| EP-3356356-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | Senomyx, Inc. (US) | 2018-08-08 | — | — | EP | disclosed |
| US-8299064-B2 | Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof | AJINOMOTO CO., INC. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20110160191-A1 | NEW FUSED POLYCYCLIC COMPOUNDS HAVING A HETEROCYCLIC RING(S) AND PHARMACEUTICAL USE THEREOF | AJINOMOTO CO., INC. (JP) | 2011-06-30 | — | — | US | disclosed |
| US-7928101-B2 | Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof | AJINOMOTO CO., INC. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-4303689-A | Flavoring with pyrazine derivatives | FIRMENICH SA (CH) | 1981-12-01 | — | — | US | disclosed |
| US-4138410-A | Flavoring agent | FIRMENICH & CIE (CH) | 1979-02-06 | — | — | US | disclosed |
| US-4126618-A | FLAVOR ADDITIVES FOR FOODS AND BEVERAGES | FIRMENICH & CIE (CH) | 1978-11-21 | — | — | US | disclosed |
| US-4085109-A | Pyridine sulfur flavoring agents | FIRMENICH & CIE (CH) | 1978-04-18 | — | — | US | disclosed |
| US-3989713-A | Pyrrylmethylthio flavoring agents | FIRMENICH & CIE (CH) | 1976-11-02 | — | — | US | disclosed |
| US-3952024-A | FLAVOR ADDITIVE FOR FOODS AND BEVERAGES | FIRMENICH & CIE (CH) | 1976-04-20 | — | — | US | disclosed |
| US-3943260-A | TETRAHYDRO-THIO-PHEN-3-ONES | FIRMENICH & CIE (CH) | 1976-03-09 | — | — | US | disclosed |
| US-3931245-A | FURYLALKYLTHIOL CARBOXYLATES | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160191-A1 | NEW FUSED POLYCYCLIC COMPOUNDS HAVING A HETEROCYCLIC RING(S) AND PHARMACEUTICAL USE THEREOF | SLC2A4, SLC2A1, SLC2A3 | ALDH1A1 1086/4885RIPK1 3325/4885ALOX5 4153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.